BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 6189212)

  • 1. Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs.
    Iordanov MS; Wong J; Bell JC; Magun BE
    Mol Cell Biol; 2001 Jan; 21(1):61-72. PubMed ID: 11113181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2-5A system in control and interferon-treated K/BALB cells infected with encephalomyocarditis virus.
    Meurs E; Krause D; Robert N; Silverman RH; Hovanessian AG
    Prog Clin Biol Res; 1985; 202():307-15. PubMed ID: 2421309
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells.
    Williams BR; Kerr IM; Gilbert CS; White CN; Ball LA
    Eur J Biochem; 1978 Dec; 92(2):455-62. PubMed ID: 216547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2-5A (pppA2'p5'A2'p5'A) and protein kinase systems in interferon-treated and control cells.
    Kerr IM; Wreschner DH; Silverman RH; Cayley PJ; Knight M
    Adv Cyclic Nucleotide Res; 1981; 14():469-78. PubMed ID: 6169260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.
    Wreschner DH; James TC; Silverman RH; Kerr IM
    Nucleic Acids Res; 1981 Apr; 9(7):1571-81. PubMed ID: 6164990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free protein synthesis and interferon action: protein kinase(s) and an oligonucleotide effector, pppA2'p5'A2'p5'A.
    Kerr IM; Williams BR; Hovanessian AG; Brown RE; Martin EM; Gilbert CS; Birdsall NJ
    Haematol Blood Transfus; 1979; 23():291-4. PubMed ID: 94574
    [No Abstract]   [Full Text] [Related]  

  • 7. 2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells.
    Silverman RH; Cayley PJ; Wreschner DH; Knight M; Gilbert CS; Brown RE; Kerr IM
    Tex Rep Biol Med; 1981-1982; 41():479-86. PubMed ID: 6189212
    [No Abstract]   [Full Text] [Related]  

  • 8. The 2-5A system and vaccinia virus.
    Esteban M; Paez E
    Prog Clin Biol Res; 1985; 202():25-34. PubMed ID: 2421306
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in experimental pathology in the People's Republic of China. Action of pppA2'p5'A2'p5'A on the immune system.
    Liu XY
    J Exp Pathol; 1984; 1(4):257-61. PubMed ID: 6086017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruiting the 2-5A system for antisense therapeutics.
    Torrence PF; Xiao W; Li G; Cramer H; Player MR; Silverman RH
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):203-6. PubMed ID: 9212911
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracellular events in interferon-treated cells.
    Hovanessian AG
    Differentiation; 1979; 15(3):139-51. PubMed ID: 393560
    [No Abstract]   [Full Text] [Related]  

  • 12. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.
    Player MR; Torrence PF
    Pharmacol Ther; 1998 May; 78(2):55-113. PubMed ID: 9623881
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.